Company Cantabio Pharmaceuticals Inc. Other OTC
Equities
CTBO
US13808X2036
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 12-02-05 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 15-05-21 |
Max Zhu
BRD | Director/Board Member | 42 | 14-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 15-05-21 |
Gergely Tóth
FOU | Founder | 51 | 12-02-05 |
Max Zhu
BRD | Director/Board Member | 42 | 14-12-31 |
Johnny He
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,549 | 6,763 ( 29.99 %) | 0 | 29.99 % |
Company contact information
Cantabio Pharmaceuticals, Inc.
2225 East Bayshore Road Suite 200
94303, Palo Alto
+
http://www.cantabio.comSector
1st Jan change | Capi. | |
---|---|---|
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |